Kimberly-Clark (NASDAQ:KMB - Get Free Report) had its price target cut by Wells Fargo & Company from $105.00 to $100.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has an "equal weight" rating on the stock. Wells Fargo & Company's price target points to a potential upside of 5.62% from the company's previous close.
A number of other research firms have also weighed in on KMB. Piper Sandler dropped their price objective on Kimberly-Clark from $121.00 to $118.00 and set an "overweight" rating for the company in a research note on Friday, September 11th. Barclays boosted their price target on Kimberly-Clark from $101.00 to $115.00 and gave the stock an "equal weight" rating in a report on Tuesday, July 21st. Bank of America dropped their price target on Kimberly-Clark from $122.00 to $120.00 and set a "buy" rating for the company in a research note on Friday, September 25th. UBS Group increased their price objective on shares of Kimberly-Clark from $115.00 to $116.00 and gave the company a "neutral" rating in a report on Wednesday, August 5th. Finally, Weiss Ratings upgraded shares of Kimberly-Clark from a "hold (c-)" rating to a "hold (c)" rating in a research report on Tuesday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Kimberly-Clark presently has an average rating of "Hold" and an average price target of $117.00.
View Our Latest Stock Analysis on KMB
Kimberly-Clark Price Performance
NASDAQ:KMB traded up $0.32 during trading hours on Monday, hitting $94.68. 352,309 shares of the stock traded hands, compared to its average volume of 4,805,285. The company has a market cap of $31.49 billion, a price-to-earnings ratio of 16.09, a price-to-earnings-growth ratio of 4.82 and a beta of 0.25. Kimberly-Clark has a 1 year low of $92.42 and a 1 year high of $123.09. The stock has a 50 day moving average price of $105.11 and a 200 day moving average price of $102.64. The company has a quick ratio of 0.69, a current ratio of 0.91 and a debt-to-equity ratio of 3.45.
Kimberly-Clark (NASDAQ:KMB - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $1.80 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.01 by ($0.21). Kimberly-Clark had a return on equity of 143.92% and a net margin of 11.79%.The firm had revenue of $4.19 billion during the quarter, compared to analysts' expectations of $4.22 billion. During the same period last year, the company earned $1.92 earnings per share. The business's revenue for the quarter was up .6% on a year-over-year basis. Sell-side analysts forecast that Kimberly-Clark will post 7.35 EPS for the current fiscal year.
Institutional Trading of Kimberly-Clark
A number of large investors have recently added to or reduced their stakes in KMB. Motiv8 Investments LLC bought a new stake in Kimberly-Clark in the fourth quarter worth $31,000. Edmond DE Rothschild Holding S.A. bought a new position in Kimberly-Clark during the second quarter valued at $32,000. Ancora Advisors LLC bought a new position in Kimberly-Clark during the second quarter valued at $32,000. Clearstead Trust LLC purchased a new position in shares of Kimberly-Clark in the 2nd quarter worth $33,000. Finally, Markowski Investments purchased a new position in shares of Kimberly-Clark in the 2nd quarter worth $36,000. Institutional investors own 76.29% of the company's stock.
About Kimberly-Clark
(
Get Free Report)
Kimberly-Clark Corporation NASDAQ: KMB is a global personal care and consumer products company that develops and markets essential products for consumers and professional customers. Its portfolio includes products in the baby and childcare, adult care, feminine care, facial and bathroom tissue, and household categories.
The company's well-known brands include Huggies diapers and wipes, Kleenex tissues, Kotex feminine care products, Cottonelle and Scott bathroom tissue, and Depend and Poise adult care products.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.